The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to our mission of saving lives and reducing the burden of disease in low-and middle-income countries. We work at the invitation of governments to support them and the private sector to create and sustain high-quality health systems.
CHAI was founded in 2002 in response to the HIV/AIDS epidemic with the goal of dramatically reducing the price of life-saving drugs and increasing access to these medicines in the countries with the highest burden of the disease. Over the following two decades, CHAI has expanded its focus. Today, along with HIV, we work with our partners to prevent and treat infectious diseases such as COVID-19, malaria, tuberculosis, and hepatitis. Our work has also expanded into cancer, diabetes, hypertension, and other non-communicable diseases, and we work to accelerate the rollout of lifesaving vaccines, reduce maternal and child mortality, combat chronic malnutrition, and increase access to assistive technology. We are investing in horizontal approaches to strengthen health systems through programs in human resources for health, digital health, and health financing. With each new and innovative program, our strategy is grounded in maximizing sustainable impact at scale, ensuring that governments lead the solutions, that programs are designed to scale nationally, and learnings are shared globally.
At CHAI, our people are our greatest asset, and none of this work would be possible without their talent, time, dedication, and passion for our mission and values. We are a highly diverse team of enthusiastic individuals across 40 countries with a broad range of skill sets and life experiences. CHAI is deeply grounded in the countries we work in, with the majority of our staff based in program countries. Learn more about our exciting work: http://www.clintonhealthaccess.org
CHAI is an Equal Opportunity Employer, and is committed to providing an environment of fairness, and mutual respect where all applicants have access to equal employment opportunities. CHAI values diversity and inclusion, and recognizes that our mission is best advanced by the leadership and contributions of people with diverse experience, backgrounds, and culture.
Program Overview
More than 300,000 women die of cervical cancer each year, despite the availability of proven prevention interventions that can dramatically reduce the burden of disease. Over 90% of these deaths occur among women in low- and middle-income countries (LMICs), where access to high-quality prevention services has historically been limited. In 2018, the WHO issued a Global Call to Action Towards Cervical Cancer Elimination, and in 2020, the Member States of the World Health Assembly adopted a Cervical Cancer Elimination Strategy, setting targets to reach 70% screening coverage and 90% treatment coverage of screen-positive women by 2030.
CHAI’s cervical cancer program works to reduce cervical cancer incidence in LMICs by expanding access to secondary prevention services, thereby preventing mortality and morbidity while lowering cancer treatment costs for health systems. The program complements CHAI’s HPV vaccines work, which supports LMICs to introduce and routinize HPV vaccination for adolescent girls (primary prevention).
The program’s approach rests on three interconnected areas of work: (1) supporting Ministries of Health to introduce optimal tools, integrate services into routine healthcare, update policy, build workforce capacity, and strengthen health systems for scale-up; (2) market shaping to improve the access and affordability of existing and new technologies for screening and precancer treatment; (3) advancing innovation, including AI-based screening, to enable same-day screening and treatment.
The program has supported over 12 countries since 2019 to scale screening and treatment services, reaching more than 1.4 million women, while working to ensure high linkage to treatment and referral, improving the affordability and access of critical tools, and advancing the development of AI-assisted tools for screening. CHAI is now supporting governments to build nationally owned costed elimination plans, identifying sustainability pathways, and bringing low-cost AI-assisted screening tools to market.
Position Overview
The Senior Program Manager (SPM) holds day-to-day operational and technical leadership across country support, costing and financing, and diagnostics strategy and execution. The SPM guides associates, senior associates on the team, quality-assures outputs before Director reviews, and represents the program in technical coordination with CHAI's global diagnostics team and other teams across the matrix. The role combines people management, technical review, and direct workstream ownership, and acts as the critical link between country-facing staff and Director-level strategy and donor engagement.
The SPM works closely with the program’s country teams and CHAI’s global diagnostics, markets, health financing, AIR/research, and HPV vaccines teams.
The role manages some senior relationships, including at Unitaid, WHO, and other major donors, and is recognized as a subject-matter expert in cervical cancer prevention.
The base location is flexible with a preference for the role to be based in a program country, pending country leadership approval. An estimated 20% of international travel time is expected.
Country support and cross-country learning
Costing and financing workstream leadership
Diagnostics strategy and AI-assisted screening
Resource mobilization and fundraising
Program reporting and financial management
People management
Program strategy
Additional responsibilities
We seek an experienced and highly motivated program manager who is passionate about eliminating cervical cancer. An ideal candidate will be described as:
Experience:
Advantages:
#jobreference3 #region3 #region4
Software Powered by ICIMS
www.icims.com